ARCHIVES

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Senators Urge study section On Clinical Cancer Research

February 4, 1994